losartan-potassium and Angina--Unstable

losartan-potassium has been researched along with Angina--Unstable* in 2 studies

Reviews

1 review(s) available for losartan-potassium and Angina--Unstable

ArticleYear
Coronary stent placement as a bridge to coronary artery bypass surgery in an unstable, anemic Jehovah's Witness patient: a case report and review of bloodless surgery techniques.
    Connecticut medicine, 1997, Volume: 61, Issue:4

    Bloodless cardiac surgery would be optimal for all patients undergoing major or complex heart surgery; however, for Jehovah's Witnesses it involves a religious law and is fundamentally mandated. In this context, we review a case of unstable angina with associated anemia requiring catheterization and definitive intervention in a Jehovah's Witness patient. Coronary stenting to stabilize the acute coronary syndrome is described with definitive total revascularization performed by coronary artery bypass graft surgery after utilizing erythropoietin and aggressive blood conservation techniques.

    Topics: Aged; Anemia; Angina, Unstable; Angioplasty, Balloon; Christianity; Coronary Artery Bypass; Coronary Vessels; Erythropoietin; Female; Humans; Stents

1997

Other Studies

1 other study(ies) available for losartan-potassium and Angina--Unstable

ArticleYear
[Prognostic Significance of Erythropoietin in Patients With Acute Coronary Syndrome].
    Kardiologiia, 2016, Volume: 56, Issue:9

    to investigate the prognostic role of erythropoietin (EPO) in patients with acute coronary syndrome (ACS).. Eighty-four patients (46 men, 38 women, mean age 63+/-11 years) with ACS were studied. Twenty-one patients had ST-elevation myocardial infarction (STEMI), 12 - non-ST-elevation myocardial infarction, 51 - unstable angina (UA). Ten patients with STEMI received thrombolytic therapy. Coronary angiography during hospitalization was criterion for exclusion from the study. Serum EPO was measured at hospital admission.. In-hospital mortality was 5%. Median EPO serum level was higher among patients who died (78.1 [27.8-143.5] vs. 9.0 [6.4-14.1]I.U./ml, p=0.004). Acute kidney injury (AKI) was observed in 7 patients with myocardial infarction (21%) and only in 1 with UA.EPO >10.5 I.U./ml was a significant predictor of AKI development (area under curve 0.73; sensitivity 71%, specificity 67%).. The results of the present study indicate that in patients with ACS admission serum level of EPO may be an important biomarker of development of AKI and in-hospital mortality.

    Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Biomarkers; Coronary Angiography; Erythropoietin; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis

2016